Literature DB >> 6432549

Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation.

A Viener, J G Brook, M Aviram.   

Abstract

Increased platelet activation has been shown to be a feature of patients with familial hypercholesterolaemia. Plasma lipoprotein concentration and composition were studied in eleven male patients with familial hypercholesterolaemia and in ten age-matched healthy controls. Increased levels of cholesterol were found in very-low- and low-density lipoproteins (53 and 275%, respectively), whereas in high-density lipoprotein, both cholesterol and apolipoprotein A-I were decreased by 21 and 26%, respectively. On incubation of gel-filtered platelets derived from normolipidaemic controls with identical concentrations of lipoproteins derived from either nomolipidaemic controls or hypercholesterolaemic patients very-low- and low-density lipoproteins from the patients caused significantly greater thrombin-induced platelet aggregation (P less than 0.01). High-density lipoprotein from normal subjects reduced platelet release by 22%, whereas the patients' high-density lipoprotein had no significant effect on platelet release. Lipoprotein-deficient plasma from both groups augmented platelet function to a similar extent. Lipoprotein composition has an important effect on platelet function in vitro. The abnormal lipid and protein composition of the lipoproteins derived from hypercholesterolaemic patients appears to be the cause of platelet hyperactivity observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432549     DOI: 10.1111/j.1365-2362.1984.tb01125.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

2.  Reduced plasma high-density lipoprotein and increased platelet activity in arterial versus venous blood.

Authors:  M Aviram; A Viener; J G Brook
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

3.  Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.

Authors:  A Shmulewitz; J G Brook; M Aviram
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

4.  Chylomicron-like particles in severe hypertriglyceridemia.

Authors:  M Aviram; Y Sechter; J G Brook
Journal:  Lipids       Date:  1985-04       Impact factor: 1.880

5.  Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.

Authors:  M Aviram; G Winterstein; J G Brook
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.